Arcturus Therapeutics
San Diego
About Arcturus Therapeutics
Arcturus Therapeutics is a late-stage clinical mRNA medicine company that focuses on developing novel RNA therapeutics for the treatment of various rare diseases. The company owns Unlocked Nucleic Acid (UNA) chemistry technology and a patent portfolio (32 patents, USPTO granted) that allow the targeting of any gene in the human genome. It was founded in 2013 and is headquartered in San Diego, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $100K – $500K
- Total funding: $489.6M
- Funding stage: IPO
- Last round: Grant (Sep 2023)
- Ticker: nasdaq:ARCT
- Website: arcturusrx.com
- Phone: 858-900-2660
Industries & Categories
Biotechnology, Genetics, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/arcturus-therapeutics-96066 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.